|
MRA-847质粒pINT,用于恶性疟原虫的转染(质粒/载体)
|
EA
|
MRA-847
|
14000
|
3-8周
|
|
MRA-846质粒pLN-ENR-GFP,用于整合到恶性疟原虫中(质粒/载体)
|
EA
|
MRA-846
|
14000
|
3-8周
|
|
MRA-845_恶性疟原虫,菌株3D7-attB(寄生原生动物)
|
EA
|
MRA-845
|
14000
|
3-8周
|
|
MRA-848质粒pcam-BSD,用于转染恶性疟原虫(质粒/载体)
|
EA
|
MRA-848
|
14000
|
3-8周
|
|
MRA-841伯氏疟原虫,NK65PbBlue(寄生原生动物)
|
EA
|
MRA-841
|
14000
|
3-8周
|
|
MRA-843恶性疟原虫,Dd2attB(寄生原生动物)
|
EA
|
MRA-843
|
14000
|
3-8周
|
|
MRA-842质粒pSE-05,用于在伯氏疟原虫中转染(质粒/载体)
|
EA
|
MRA-842
|
14000
|
3-8周
|
|
MRA-844质粒pCG6-attB,用于整合到恶性疟原虫中(质粒/载体)
|
EA
|
MRA-844
|
14000
|
3-8周
|
|
MRA-831文氏疟原虫,197CR27(寄生原生动物)
|
EA
|
MRA-831
|
14000
|
3-8周
|
|
MRA-832文氏疟原虫亚种.喀麦隆,8EL8(寄生原生动物)
|
EA
|
MRA-832
|
14000
|
3-8周
|
|
MRA-833_Hybridoma7H8/50Anti-PlasmodiumfalciparumRhoptry-AssociatedProtein1(RAP1)(细胞库)
|
EA
|
MRA-833
|
14000
|
3-8周
|
|
MRA-834杂交瘤8G10/48抗恶性疟原虫裂殖子表面蛋白2(MSP2)(细胞库)
|
EA
|
MRA-834
|
14000
|
3-8周
|
|
MRA-823_恶性疟原虫,菌株LF4(寄生原生动物)
|
EA
|
MRA-823
|
14000
|
3-8周
|
|
MRA-826_Plasmodiumvinckeibrucechwatti,1/69(寄生原生动物)
|
EA
|
MRA-826
|
14000
|
3-8周
|
|
MRA-824文氏疟原虫,v67(寄生原生动物)
|
EA
|
MRA-824
|
14000
|
3-8周
|
|
MRA-822G恶性疟原虫基因组DNA,MT/S1株(核酸)
|
EA
|
MRA-822G
|
14000
|
3-8周
|
|
MRA-822_恶性疟原虫,菌株MT/s1(寄生原生动物)
|
EA
|
MRA-822
|
14000
|
3-8周
|
|
MRA-823G_来自恶性疟原虫的基因组DNA,菌株LF4(核酸)
|
EA
|
MRA-823G
|
14000
|
3-8周
|
|
MRA-820_恶性疟原虫,V1/S(寄生原生动物)
|
EA
|
MRA-820
|
14000
|
3-8周
|
|
MRA-821恶性疟原虫,KMWII株(寄生原生动物)
|
EA
|
MRA-821
|
14000
|
3-8周
|